OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Chimerix Inc/  US16934W1062  /

NASDAQ
23/05/2024  22:00:00 Chg. -0.0208 Volume Bid01:57:01 Ask01:57:01 High Low
0.9422USD -2.16% 188,276
Turnover: 172,658.6511		 0.9301Bid Size: 300 0.9750Ask Size: 1,000 0.9700 0.9301
GlobeNewswire 01/05 Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire 24/04 Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, ...
GlobeNewswire 16/04 Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 21/03 Chimerix Appoints Marc D. Kozin to Board of Directors
GlobeNewswire 29/02 Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
GlobeNewswire 22/02 Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Upd...
GlobeNewswire 06/02 atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
GlobeNewswire 29/12/2023 Chimerix Appoints Lisa Decker to Board of Directors
GlobeNewswire 04/12/2023 Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
GlobeNewswire 24/11/2023 Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 16/11/2023 Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating an...
GlobeNewswire 02/11/2023 Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
GlobeNewswire 26/10/2023 Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on Novembe...
GlobeNewswire 05/09/2023 Chimerix to Participate in Upcoming Investor Conferences
GlobeNewswire 16/08/2023 Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC20...
GlobeNewswire 16/08/2023 Teknova Announces New Board Member, Martha J. Demski
GlobeNewswire 21/03/2022 Chimerix to Present at Maxim Group 2022 Virtual Growth Conference
GlobeNewswire 01/03/2022 Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
GlobeNewswire 28/02/2022 Chimerix to Present at Cowen and Company 42nd Annual Health Care Conference
GlobeNewswire 24/02/2022 Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiative (READDI) ...
GlobeNewswire 22/02/2022 Chimerix to Report Fourth Quarter and Year End 2021 Financial Results and Provide an Operational Upd...
GlobeNewswire 20/01/2022 Chimerix to Present at B. Riley Virtual Oncology Conference
GlobeNewswire 03/01/2022 Chimerix to Present at Virtual H.C. Wainwright BioConnect 2022 Conference
GlobeNewswire 11/12/2021 Annual Changes to the Nasdaq Biotechnology Index
GlobeNewswire 19/11/2021 Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Pre...